1.Pre-hospital Korean Triage and Acuity Scale: the results of first and second pilot projects
Changshin KANG ; Han Joo CHOI ; Sang-Il KIM ; Yong Oh KIM ; Jung-Youn KIM ; Jungho KIM ; Hyun NOH ; Hyun Ho RYU ; Jung Hee WEE ; Gyuuk HWANG ; Ki Jeong HONG ; Jae Yun AHN ; Chun Song YOUN ; Eunsil KO ; Minhee LEE ; Sung-keun KO ; Tae Young LEE ; Eul Hee ROH ; Joonbum PARK
Journal of the Korean Society of Emergency Medicine 2024;35(1):6-15
		                        		
		                        			
		                        			 While the Korean Triage and Acuity Scale (KTAS) was introduced in 2016 as a tool to identify patients at risk of catastrophic events, including death in the ED, the triage system for the pre-hospital stage still lacks evidence. The pre-hospital stage is characterized by time-sensitive and complex scenarios, where rapid and accurate decision-making is paramount to optimize patient outcomes. Despite the vital role of pre-hospital care providers, the invalidated and subjective current triage system consisting of 4-stages is still used at the pre-hospital stage, and hence, it needs to be modified to be more objective, standardized, and reliable. To improve the Korean emergency medical system, the pre-hospital KTAS (Pre-KTAS) was developed in 2020, and then two pilot projects were conducted in 2022 and 2023. This paper not only reveals the results of the first and second pilot projects for Pre-KTAS but also highlights the potential benefits of using this newly developed triage tool in the pre-hospital setting. Furthermore, this paper suggests ways to improve the emergency medical system (EMS) in Korea by improving patient safety, resource allocation, and overall emergency response efficiency. 
		                        		
		                        		
		                        		
		                        	
2.Compositional changes in fecal microbiota in a new Parkinson’s disease model:C57BL/6‑Tg(NSE‑haSyn) mice
Ji Eun KIM ; Ki Chun KWON ; You Jeong JIN ; Ayun SEOL ; Hee Jin SONG ; Yu Jeong ROH ; Tae Ryeol KIM ; Eun Seo PARK ; Gi Ho PARK ; Ji Won PARK ; Young Suk JUNG ; Joon Yong CHO ; Dae Youn HWANG
Laboratory Animal Research 2023;39(4):371-384
		                        		
		                        			 Background:
		                        			The gut–brain axis (GBA) in Parkinson’s disease (PD) has only been investigated in limited mice models despite dysbiosis of the gut microbiota being considered one of the major treatment targets for neurodegenerative disease. Therefore, this study examined the compositional changes of fecal microbiota in novel transgenic (Tg) mice overexpressing human α-synuclein (hαSyn) proteins under the neuron-specific enolase (NSE) to analyze the potential as GBA model. 
		                        		
		                        			Results:
		                        			The expression level of the αSyn proteins was significantly higher in the substantia nigra and striatum of NSEhαSyn Tg mice than the Non-Tg mice, while those of tyrosine hydroxylase (TH) were decreased in the same group. In addition, a decrease of 72.7% in the fall times and a 3.8-fold increase in the fall number was detected in NSE-hαSyn Tg mice. The villus thickness and crypt length on the histological structure of the gastrointestinal (GI) tract decreased in NSE-hαSyn Tg mice. Furthermore, the NSE-hαSyn Tg mice exhibited a significant increase in 11 genera, including Scatolibacter, Clostridium, Feifania, Lachnoclostridium, and Acetatifactor population, and a decrease in only two genera in Ligilactobacillus and Sangeribacter population during enhancement of microbiota richness and diversity. 
		                        		
		                        			Conclusions
		                        			The motor coordination and balance dysfunction of NSE-hαSyn Tg mice may be associated with compositional changes in gut microbiota. In addition, these mice have potential as a GBA model. 
		                        		
		                        		
		                        		
		                        	
3.Chemosensitivity to doxorubicin in primary cells derived from tumor of FVB/N‑Trp53tm1Hw1 with TALEN‑mediated Trp53 mutant gene
Woobin YUN ; Ji Eun KIM ; You Jeong JIN ; Yu Jeong ROH ; Hee Jin SONG ; Ayun SEOL ; Tae Ryeol KIM ; Kyeong Seon MIN ; Eun Seo PARK ; Gi Ho PARK ; Hyun Gu KANG ; Yeon Shik CHOI ; Dae Youn HWANG
Laboratory Animal Research 2023;39(4):287-297
		                        		
		                        			 Background:
		                        			To evaluate the chemosensitivity to doxorubicin (DOX) in two primary cells derived from a tumor of FVB/N-Trp53tm1Hw1 knockout (KO) mice with TALEN-mediated Trp53 mutant gene, we evaluated the cell survivability, cell cycle distribution, apoptotic cell numbers and apoptotic protein expression in solid tumor cells and ascetic tumor cells treated with DOX. 
		                        		
		                        			Results:
		                        			The primary tumor cells showed a significant (P < 0.05) defect for UV-induced upregulation of the Trp53 pro-tein, and consisted of different ratios of leukocytes, fibroblasts, epithelial cells and mesenchymal cells. The  IC50 level to DOX was lower in both primary cells (IC50 = 0.12 μM and 0.20 μM) as compared to the CT26 cells (IC50 = 0.32  μM), although the solid tumor was more sensitive. Also, the number of cells arrested at the G0/G1 stage was significantly decreased (24.7–23.1% in primary tumor cells treated with DOX, P < 0.05) while arrest at the G2 stage was enhanced to 296.8–254.3% in DOX-treated primary tumor cells compared with DOX-treated CT26 cells. Furthermore, apoptotic cells of early and late stage were greatly increased in the two primary cell-lines treated with DOX when compared to same conditions for CT26 cells. However, the Bax/Bcl-2 expression level was maintained constant in the primary tumor and CT26 cells. 
		                        		
		                        			Conclusions
		                        			To the best of our knowledge, these results are the first to successfully detect an alteration in chemosensitivity to DOX in solid tumor cells and ascetic tumor cells derived from tumor of FVB/N-Trp53tm1Hw1 mice TALENmediated Trp53 mutant gene. 
		                        		
		                        		
		                        		
		                        	
4.Myelin Content in Mild Traumatic Brain Injury Patients with Post-Concussion Syndrome: Quantitative Assessment with a Multidynamic Multiecho Sequence
Roh-Eul YOO ; Seung Hong CHOI ; Sung-Won YOUN ; Moonjung HWANG ; Eunkyung KIM ; Byung-Mo OH ; Ji Ye LEE ; Inpyeong HWANG ; Koung Mi KANG ; Tae Jin YUN ; Ji-hoon KIM ; Chul-Ho SOHN
Korean Journal of Radiology 2022;23(2):226-236
		                        		
		                        			 Objective:
		                        			This study aimed to explore the myelin volume change in patients with mild traumatic brain injury (mTBI) with post-concussion syndrome (PCS) using a multidynamic multiecho (MDME) sequence and automatic whole-brain segmentation. 
		                        		
		                        			Materials and Methods:
		                        			Forty-one consecutive mTBI patients with PCS and 29 controls, who had undergone MRI including the MDME sequence between October 2016 and April 2018, were included. Myelin volume fraction (MVF) maps were derived from the MDME sequence. After three dimensional T1-based brain segmentation, the average MVF was analyzed at the bilateral cerebral white matter (WM), bilateral cerebral gray matter (GM), corpus callosum, and brainstem. The Mann–Whitney U-test was performed to compare MVF and myelin volume between patients with mTBI and controls. Myelin volume was correlated with neuropsychological test scores using the Spearman rank correlation test. 
		                        		
		                        			Results:
		                        			The average MVF at the bilateral cerebral WM was lower in mTBI patients with PCS (median [interquartile range], 25.2% [22.6%–26.4%]) than that in controls (26.8% [25.6%–27.8%]) (p = 0.004). The region-of-interest myelin volume was lower in mTBI patients with PCS than that in controls at the corpus callosum (1.87 cm3 [1.70–2.05 cm3 ] vs. 2.21 cm3 [1.86– 3.46 cm3 ]; p = 0.003) and brainstem (9.98 cm3 [9.45–11.00 cm3 ] vs. 11.05 cm3 [10.10–11.53 cm3 ]; p = 0.015). The total myelin volume was lower in mTBI patients with PCS than that in controls at the corpus callosum (0.45 cm3 [0.39–0.48 cm3 ] vs. 0.48 cm3 [0.45–0.54 cm3 ]; p = 0.004) and brainstem (1.45 cm3 [1.28–1.59 cm3 ] vs. 1.54 cm3 [1.42–1.67 cm3 ]; p = 0.042). No significant correlation was observed between myelin volume parameters and neuropsychological test scores, except for the total myelin volume at the bilateral cerebral WM and verbal learning test (delayed recall) (r = 0.425; p = 0.048). 
		                        		
		                        			Conclusion
		                        			MVF quantified from the MDME sequence was decreased at the bilateral cerebral WM in mTBI patients with PCS. The total myelin volumes at the corpus callosum and brainstem were decreased in mTBI patients with PCS due to atrophic changes. 
		                        		
		                        		
		                        		
		                        	
5.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 4. Adult advanced life support
Jaehoon OH ; Kyoung-Chul CHA ; Jong-Hwan LEE ; Seungmin PARK ; Dong-Hyeok KIM ; Byung Kook LEE ; Jung Soo PARK ; Woo Jin JUNG ; Dong Keon LEE ; Young Il ROH ; Tae Youn KIM ; Sung Phil CHUNG ; Young-Min KIM ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Gyu Chong CHO ; Ai-Rhan Ellen KIM ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S26-S40
		                        		
		                        		
		                        		
		                        	
6.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 2. Environment for cardiac arrest survival and the chain of survival
Sung Oh HWANG ; Kyoung-Chul CHA ; Woo Jin JUNG ; Young-Il ROH ; Tae Youn KIM ; Sung Phil CHUNG ; Young-Min KIM ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Gyu Chong CHO ; Ai-Rhan Ellen KIM ;
Clinical and Experimental Emergency Medicine 2021;8(S):S8-S14
		                        		
		                        		
		                        		
		                        	
7.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 1. Update process and highlights
Sung Oh HWANG ; Kyoung-Chul CHA ; Woo Jin JUNG ; Young-Il ROH ; Tae Youn KIM ; Sung Phil CHUNG ; Young-Min KIM ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Gyu Chong CHO ; Ai-Rhan Ellen KIM ;
Clinical and Experimental Emergency Medicine 2021;8(S):S1-S7
		                        		
		                        		
		                        		
		                        	
8.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 4. Adult advanced life support
Jaehoon OH ; Kyoung-Chul CHA ; Jong-Hwan LEE ; Seungmin PARK ; Dong-Hyeok KIM ; Byung Kook LEE ; Jung Soo PARK ; Woo Jin JUNG ; Dong Keon LEE ; Young Il ROH ; Tae Youn KIM ; Sung Phil CHUNG ; Young-Min KIM ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Gyu Chong CHO ; Ai-Rhan Ellen KIM ; Sung Oh HWANG ;
Clinical and Experimental Emergency Medicine 2021;8(S):S26-S40
		                        		
		                        		
		                        		
		                        	
9.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 2. Environment for cardiac arrest survival and the chain of survival
Sung Oh HWANG ; Kyoung-Chul CHA ; Woo Jin JUNG ; Young-Il ROH ; Tae Youn KIM ; Sung Phil CHUNG ; Young-Min KIM ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Gyu Chong CHO ; Ai-Rhan Ellen KIM ;
Clinical and Experimental Emergency Medicine 2021;8(S):S8-S14
		                        		
		                        		
		                        		
		                        	
10.2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 1. Update process and highlights
Sung Oh HWANG ; Kyoung-Chul CHA ; Woo Jin JUNG ; Young-Il ROH ; Tae Youn KIM ; Sung Phil CHUNG ; Young-Min KIM ; June Dong PARK ; Han-Suk KIM ; Mi Jin LEE ; Sang-Hoon NA ; Gyu Chong CHO ; Ai-Rhan Ellen KIM ;
Clinical and Experimental Emergency Medicine 2021;8(S):S1-S7
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail